← Browse by Condition
Medical Condition
medulloblastoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 4
NCT05106296 Phase 1
Recruiting
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Enrollment
37 pts
Location
United States
Sponsor
Theodore S. Johnson
NCT04081701 Phase 4
Recruiting
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Enrollment
200 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC